BONNIE STEFFENS: Open Payments
NPI 1407136823 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 88 payments from 13 companies in 2025. Trend: 2023 $2,042 · 2024 $1,965 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $546 |
| EMD Serono, Inc. | 20 | $235 |
| ACADIA Pharmaceuticals Inc | 17 | $163 |
| Celgene Corporation | 4 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| ARGENX US, INC. | 3 | $59 |
| TG Therapeutics, Inc. | 2 | $33 |
| UCB, Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
Products named: QULIPTA, BOTOX, NUPLAZID, ZEPOSIA, KESIMPTA, UBRELVY, VYVGART, BRIUMVI.
Industry payments across UT — which companies pay providers there.
